VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV

Clinical trial NCT01158157 · COMPLETED

Trial details

NCT number: NCT01158157
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Smallpox Vaccine Adverse Reaction

Start date: 2010-09-13
Primary completion: 2012-02-14
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.